---
gsd_state_version: 1.0
milestone: v1.0
milestone_name: milestone
status: planning
stopped_at: Completed 01-02-PLAN.md
last_updated: "2026-05-06T19:36:33Z"
last_activity: 2026-05-06 - Completed Phase 1 Plan 02 A1C band rubric and routing contract
progress:
  total_phases: 5
  completed_phases: 0
  total_plans: 13
  completed_plans: 2
  percent: 15
---

# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-05-04)

**Core value:** Revora must give a clear, evidence-grounded, permission-first answer to "Can I eat this?" in under 5 seconds without increasing food anxiety.
**Current focus:** Phase 1 - Claims Boundary, Evidence Pack, and Safety Spec

## Current Position

Phase: 1 of 5 (Claims Boundary, Evidence Pack, and Safety Spec)
Plan: 2 of 3 in current phase
Status: In progress
Last activity: 2026-05-06 - Completed Phase 1 Plan 02 A1C band rubric and routing contract

Progress: [██░░░░░░░░] 15%

## Performance Metrics

**Velocity:**
- Total plans completed: 2
- Average duration: 6 min
- Total execution time: 0.2 hours

**By Phase:**

| Phase | Plans | Total | Avg/Plan |
|-------|-------|-------|----------|
| 1. Claims Boundary, Evidence Pack, and Safety Spec | 2 | 12 min | 6 min |
| 2. Guardrailed Inference Core and Eval Harness | 0 | 0 min | - |
| 3. Public Mobile Permission Check | 0 | 0 min | - |
| 4. Privacy-Minimal Launch Controls | 0 | 0 min | - |
| 5. Community Launch and Founder Review Loop | 0 | 0 min | - |

**Recent Trend:**
- Last 5 plans: 01-01 (10 min), 01-02 (2 min)
- Trend: Phase 1 refinement work is moving faster now that the safety contract foundation exists.

## Accumulated Context

### Decisions

Decisions are logged in PROJECT.md Key Decisions table.
Recent decisions affecting current work:

- Phase 1: Keep Revora prediabetes-only, qualitative, and explicitly non-medical.
- Phase 2: Treat harmful SAFE classifications as the launch-blocking quality risk.
- Phase 3: Preserve the one-page no-login mobile flow as the MVP interaction model.
- Phase 4: Keep telemetry privacy-minimal and avoid raw food/A1C retention by default.
- Phase 5: Defer scanner, auth, saved history, and payments unless launch evidence clears the expansion gate.
- [Phase 01]: Active claims validation scans only approved active ledger rows so policy docs can record banned language without false positives.
- [Phase 01]: Evidence sources stay attached to narrow allowed-use statements and explicit do-not-claim limits rather than acting as broad citation permission.
- [Phase 01]: The validator remains dependency-free and relies only on Node.js built-ins so Phase 1 has no package-install requirement.
- [Phase 01]: A1C routing is a pre-classification scope gate, not a model judgment or diagnosis.
- [Phase 01]: Higher A1C bands increase caution qualitatively without implying exact glucose or future-A1C prediction.
- [Phase 01]: Out-of-scope A1C values below 5.7 and 6.5+ never return SAFE, MODERATE, or HIGH.

### Pending Todos

None yet.

### Blockers/Concerns

- Claims-safe wording, disclaimer language, and launch copy must stay consistent across prompt, UI, and community posts.
- Harmful SAFE regressions remain the primary launch blocker until the evaluation suite is green.
- Telemetry beyond pageviews must stay redacted or remain out of scope.

## Session Continuity

Last session: 2026-05-06T19:36:33Z
Stopped at: Completed 01-02-PLAN.md
Resume file: None
